Orglide MV 2mg/500mg/0.2mg Tablet SR
Marketer
Orlife Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Orglide MV 2mg/500mg/0.2mg Tablet SR
Diabexe-Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Diabexe-Trio should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any heart history before commencing treatment; it may be unsuitable. Pregnant or lactating individuals must consult their doctor prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.
Primary Ingredients of Orglide MV 2mg/500mg/0.2mg Tablet SR
The provided text is "undefined," which lacks meaning and cannot be rephrased.
Uses of Orglide MV 2mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Orglide MV 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume Orglide MV 2mg/500mg/0.2mg Extended-Release tablets on an empty stomach.
Common Side effects of Orglide MV 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Orglide MV 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Orglide MV 2mg/500mg/0.2mg Sustained-Release Tablets should be administered on an empty stomach.
How Orglide MV 2mg/500mg/0.2mg Tablet SR works:
Orglide MV, a sustained-release tablet (2mg/500mg/0.2mg), contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Orglide MV 2mg/500mg/0.2mg SR Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Orglide MV 2mg/500mg/0.2mg Extended-Release Tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Orglide MV tablets (2mg/500mg/0.2mg) are likely not suitable for use while breastfeeding. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Orglide MV 2mg/500mg/0.2mg Tablet SR carries a high risk in individuals with kidney impairment and is best avoided. Patients with severe kidney disease should definitely not take this medication. A physician's consultation is advised.
LiverCAUTION
Patients with liver impairment should use Orglide MV 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low Orglide MV 2mg/500mg/0.2mg SR tablet dosage; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Orglide MV 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a dose of Orglide MV 2mg/500mg/0.2mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orglide MV 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently